BMS 181184

Known as: BMS-181184 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-1999
012319921999

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
The pradimicins are a new class of antifungal agents with activity against the majority of human fungal pathogens. In this study… (More)
Is this relevant?
1998
1998
The activity of the pradimicin derivative BMS 181184 was evaluated in a model of invasive pulmonary aspergillosis in persistently… (More)
  • figure 1
  • figure 3
  • figure 2
  • table 1
  • table 2
Is this relevant?
1997
1997
BMS-181184 is a water-soluble derivative of the pradimicin group of antifungal compounds. We determined the in vitro activities… (More)
Is this relevant?
Review
1997
Review
1997
Pradimicins are a new class of antifungal compounds currently undergoing preclinical and early phase I clinical trials. The… (More)
  • table 1
  • figure 1
Is this relevant?
Review
1997
Review
1997
Fungal infections are on the rise as the number of patients with compromised immune systems continues to increase. The need for… (More)
Is this relevant?
1996
1996
We compared the in vitro activity of BMS-181184, the first compound of a new class of antifungal agents, the pradimicins, with… (More)
Is this relevant?
1995
1995
A new pradimicin derivative, BMS-181184, was compared with amphotericin B and fluconazole against 249 strains from 35 fungal… (More)
Is this relevant?
1993
1993
BMS-181184 is a new semisynthetic pradimicin derivative with a broad-spectrum antifungal activity. In a search for actinomycetes… (More)
Is this relevant?
1993
1993
BMY-28864 (BMS-181184), a water-soluble pradimicin derivative, specifically bound on the yeast cell surface in the presence of… (More)
Is this relevant?
1992
1992
The pradimicins1 ~ 4) and benanomicins5) are family of benzo[a]naphthacenequinone antifungal agents which have comeinto… (More)
  • figure 1
  • table 1
  • table 2
  • table 4
  • table 3
Is this relevant?